Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

scent theory KEEP CLEAN Moisturizing Hand Sanitizer

CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Terminated Chemical / undeclared Real Clean Distribuciones SA de CV D-1580-2020
Class II · Moderate risk

scent theory KEEP IT CLEAN

CGMP Deviations: Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Terminated Chemical / undeclared Real Clean Distribuciones SA de CV D-1579-2020
Class III · Low risk

Leucovorin Calcium Tablets USP

Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code.

Terminated Failed specification West-Ward Columbus Inc NDC 0054-4497-10 D-1490-2020
Class II · Moderate risk

Mibelas 24 Fe

Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. D-1502-2020
Class II · Moderate risk

Lisinopril Tablets USP

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68001-334-08 D-1413-2020
Class II · Moderate risk

Lidocaine Patch 5%

Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 0591-3525-30 D-1492-2020
Class III · Low risk

Fosaprepitant for Injection

Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 63323-972-10 D-1391-2020

Recalls by year